İSKENDER, B. Et Al. 2015. Myrtucommulone A treatment decreases pluripotency and multipotency associated marker expression in bladder cancer cell line HTB 9. 3rd Anticancer Agent Development Congress (European Association for Cancer research sponsored) .

İSKENDER, B., İZGİ, K., KARACA, H., & CANATAN, H., (2015). Myrtucommulone A treatment decreases pluripotency and multipotency associated marker expression in bladder cancer cell line HTB 9 . 3rd Anticancer Agent Development Congress (European Association for Cancer research sponsored)

İSKENDER, BANU Et Al. "Myrtucommulone A treatment decreases pluripotency and multipotency associated marker expression in bladder cancer cell line HTB 9," 3rd Anticancer Agent Development Congress (European Association for Cancer research sponsored), 2015

İSKENDER, BANU Et Al. "Myrtucommulone A treatment decreases pluripotency and multipotency associated marker expression in bladder cancer cell line HTB 9." 3rd Anticancer Agent Development Congress (European Association for Cancer research sponsored) , 2015

İSKENDER, B. Et Al. (2015) . "Myrtucommulone A treatment decreases pluripotency and multipotency associated marker expression in bladder cancer cell line HTB 9." 3rd Anticancer Agent Development Congress (European Association for Cancer research sponsored) .

@conferencepaper{conferencepaper, author={BANU İSKENDER Et Al. }, title={Myrtucommulone A treatment decreases pluripotency and multipotency associated marker expression in bladder cancer cell line HTB 9}, congress name={3rd Anticancer Agent Development Congress (European Association for Cancer research sponsored)}, city={}, country={}, year={2015}}